82 FR 54389 - National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Federal Register Volume 82, Issue 221 (November 17, 2017)

Page Range		54389-54389
FR Document		2017-24898

Federal Register, Volume 82 Issue 221 (Friday, November 17, 2017)

[Federal Register Volume 82, Number 221 (Friday, November 17, 2017)]
[Notices]
[Page 54389]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-24898]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Alcohol Abuse and Alcoholism; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Alcohol Abuse and 
Alcoholism Special Emphasis Panel; AA-1 and AA-4 Conflict 
Applications.
    Date: December 11, 2017.
    Time: 1:00 p.m. to 3:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, National Institute on 
Alcohol Abuse and Alcoholism, 5635 Fishers Lane, Bethesda, MD 20892 
(Telephone Conference Call).
    Contact Person: Philippe Marmillot, Ph.D., National Institutes 
of Health, National Institute on Alcohol Abuse and Alcoholism, 5635 
Fishers Lane, Room 2017, Bethesda, MD 20892, 301-443-2861, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.271, 
Alcohol Research Career Development Awards for Scientists and 
Clinicians; 93.272, Alcohol National Research Service Awards for 
Research Training; 93.273, Alcohol Research Programs; 93.891, 
Alcohol Research Center Grants; 93.701, ARRA Related Biomedical 
Research and Research Support Awards, National Institutes of Health, 
HHS)

    Dated: November 13, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-24898 Filed 11-16-17; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 82, No. 221 / Friday, November 17, 2017 / Notices 54389

Date: December 8, 2017. Name of Committee: National Heart, Lung, 5635 Fishers Lane, Room 2017, Bethesda, MD
Time: 9:00 a.m. to 4:00 p.m. and Blood Institute Special Emphasis Panel; 20892, 301–443–2861, marmillotp@
Agenda: To review and evaluate grant NHLBI SBIR Phase IIB Bridge Awards. mail.nih.gov.
applications. Date: December 7, 2017. (Catalogue of Federal Domestic Assistance
Place: National Institutes of Health, 6701 Time: 9:30 a.m. to 5:00 p.m. Program Nos. 93.271, Alcohol Research
Rockledge Drive, Room 7194, Bethesda, MD Agenda: To review and evaluate grant Career Development Awards for Scientists
20892 (Telephone Conference Call). applications. and Clinicians; 93.272, Alcohol National
Contact Person: Charles Joyce, Ph.D., Place: Embassy Suites at the Chevy Chase Research Service Awards for Research
Scientific Review Officer, Office of Scientific Pavilion, 4300 Military Road NW., Training; 93.273, Alcohol Research Programs;
Review/DERA National Heart, Lung, and Washington, DC 20015. 93.891, Alcohol Research Center Grants;
Blood Institute, 6701 Rockledge Drive, Room Contact Person: Susan Wohler Sunnarborg, 93.701, ARRA Related Biomedical Research
7194, Bethesda, MD 20892–7924, 301–827– Ph.D., Scientific Review Officer, Office of and Research Support Awards, National
Scientific Review/DERA, National Heart, Institutes of Health, HHS)
7939, cjoyce@nhlbi.nih.gov.
Lung, and Blood Institute, 6701 Rockledge
(Catalogue of Federal Domestic Assistance Drive, Room 7182, Bethesda, MD 20892, Dated: November 13, 2017.
Program Nos. 93.233, National Center for susan.sunnarborg@nih.gov, 301–827–7987. Melanie J. Pantoja,
Sleep Disorders Research; 93.837, Heart and Program Analyst, Office of Federal Advisory
(Catalogue of Federal Domestic Assistance
Vascular Diseases Research; 93.838, Lung Committee Policy.
Program Nos. 93.233, National Center for
Diseases Research; 93.839, Blood Diseases Sleep Disorders Research; 93.837, Heart and [FR Doc. 2017–24898 Filed 11–16–17; 8:45 am]
and Resources Research, National Institutes Vascular Diseases Research; 93.838, Lung BILLING CODE 4140–01–P
of Health, HHS) Diseases Research; 93.839, Blood Diseases
Dated: November 9, 2017. and Resources Research, National Institutes
Michelle Trout, of Health, HHS) DEPARTMENT OF HEALTH AND
Program Analyst, Office of Federal Advisory Dated: November 13, 2017. HUMAN SERVICES
Committee Policy. Michelle Trout,
[FR Doc. 2017–24897 Filed 11–16–17; 8:45 am] Program Analyst, Office of Federal Advisory National Institutes of Health
BILLING CODE 4140–01–P Committee Policy.
National Cancer Institute; Notice of
[FR Doc. 2017–24896 Filed 11–16–17; 8:45 am]
Closed Meeting
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND Pursuant to section 10(d) of the
HUMAN SERVICES Federal Advisory Committee Act, as
DEPARTMENT OF HEALTH AND amended, notice is hereby given of the
National Institutes of Health HUMAN SERVICES following meeting.
The meeting will be closed to the
National Heart, Lung, and Blood National Institutes of Health public in accordance with the
Institute; Notice of Closed Meetings provisions set forth in sections 552b(c)
National Institute on Alcohol Abuse (4) and 552b(c) (6), Title 5 U.S.C., as
Pursuant to section 10(d) of the and Alcoholism; Notice of Closed amended. The purpose of this meeting
Federal Advisory Committee Act, as Meeting is to evaluate requests for preclinical
amended, notice is hereby given of development resources for potential
meetings of the NHLBI Special Pursuant to section 10(d) of the
Federal Advisory Committee Act, as new therapeutics for the treatment of
Emphasis Panel. cancer. The outcome of the evaluation
amended, notice is hereby given of the
The meetings will be closed to the following meeting. will provide information to internal NCI
public in accordance with the The meeting will be closed to the committees that will decide whether
provisions set forth in sections public in accordance with the NCI should support requests and make
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., provisions set forth in sections available contract resources for
as amended. The grant applications and 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., development of the potential
the discussions could disclose as amended. The grant applications and therapeutic to improve the treatment of
confidential trade secrets or commercial the discussions could disclose various forms of cancer. The research
property such as patentable material, confidential trade secrets or commercial proposals and the discussions could
and personal information concerning property such as patentable material, disclose confidential trade secrets or
individuals associated with the grant and personal information concerning commercial property such as patentable
applications, the disclosure of which individuals associated with the grant material, and personal information
would constitute a clearly unwarranted applications, the disclosure of which concerning individuals associated with
invasion of personal privacy. would constitute a clearly unwarranted the proposed research projects, the
Name of Committee: National Heart, Lung, invasion of personal privacy. disclosure of which would constitute a
and Blood Institute Special Emphasis Panel; Name of Committee: National Institute on
clearly unwarranted invasion of
NHLBI SBIR Phase IIB Small Market Awards. Alcohol Abuse and Alcoholism Special personal privacy.
Date: December 7, 2017. Emphasis Panel; AA–1 and AA–4 Conflict Name of Committee: National Cancer
Time: 8:00 a.m. to 9:30 a.m. Applications. Institute Special Emphasis Panel; Oct2017
Agenda: To review and evaluate grant Date: December 11, 2017. Cycle 27 NExT SEP Committee Meeting.
applications. Time: 1:00 p.m. to 3:30 p.m. Date: December 13, 2017.
Place: Embassy Suites at the Chevy Chase Agenda: To review and evaluate grant Time: 8:30 a.m. to 4:30 p.m.
sradovich on DSK3GMQ082PROD with NOTICES

Pavilion, 4300 Military Road NW., applications. Agenda: To evaluate the NCI Experimental
Washington, DC 20015. Place: National Institutes of Health, Therapeutics Program Portfolio.
Contact Person: Susan Wohler Sunnarborg, National Institute on Alcohol Abuse and Place: National Institutes of Health, 9000
Ph.D., Scientific Review Officer, Office of Alcoholism, 5635 Fishers Lane, Bethesda, Rockville Pike, Building 31, Wing C, 6th
Scientific Review/DERA National Heart, MD 20892 (Telephone Conference Call). Floor, Conference Room 10, Bethesda, MD
Lung, and Blood Institute, 6701 Rockledge Contact Person: Philippe Marmillot, Ph.D., 20892.
Drive, Room 7182, Bethesda, MD 20892, National Institutes of Health, National Contact Persons: Barbara Mroczkowski,
susan.sunnarborg@nih.gov, 301–827–7987. Institute on Alcohol Abuse and Alcoholism, Ph.D., Executive Secretary, Discovery

VerDate Sep<11>2014 18:32 Nov 16, 2017 Jkt 244001 PO 00000 Frm 00074 Fmt 4703 Sfmt 4703 E:\FR\FM\17NON1.SGM 17NON1

Document Created: 2017-11-17 05:14:52
Document Modified: 2017-11-17 05:14:52

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		December 11, 2017.
FR Citation		82 FR 54389